Loading clinical trials...
Loading clinical trials...
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Conditions
Interventions
4 mg CLS-TA Suprachoriodal Injection
Locations
10
United States
Retinal Consultants of Arizona
Phoenix, Arizona, United States
Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
Northern California Retina Vitreous Associates Medical Group, Inc.
Mountain View, California, United States
Retina Group of Florida
Fort Lauderdale, Florida, United States
Marietta Eye Clinic
Marietta, Georgia, United States
Midwest Eye Retina Practicing at Midwest Eye Institute
Indianapolis, Indiana, United States
Start Date
April 4, 2017
Primary Completion Date
January 24, 2018
Completion Date
January 24, 2018
Last Updated
June 23, 2021
NCT07218770
NCT05486468
NCT02706704
NCT06431373
NCT07262437
NCT07176130
Lead Sponsor
Clearside Biomedical, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions